Fundraising FoxHatteras Venture Partners — 2023 Investments
4 investments dated 2023 · listed companies and verified rows first · show all
Aer Therapeutics develops a science-driven therapeutic aimed at eliminating mucus plugs in the lungs to treat muco-obstructive lung diseases such as COPD and asthma.
BiotechHealthtechMedical DevicesRaleigh, US
Thomas Mathers(Executive Officer, Director)inJames Shaffer(Executive Officer, Director)John Fahy(Director)in
BoardChristy Shaffer(Director)inRishi Gupta(Director)inTim Shannon(Director)in
Co-investorsOrbiMedCanaan PartnersPappas Capital
ilumivu builds software platforms for behavioral and clinical research, including tools for running clinical trials, patient engagement, and multisite collaborative research using wearable and mobile technology.
AI & Machine LearningDigital HealthHealthtechMental HealthSaaSFairview, US
Mark Tuomenoksa(Co-Founder & Chief Technology Officer)inLauren Pierce Flickinger(Chief Executive Officer)inKate Rahimzadeh(Chief Operating Officer)inSandeep Goel(Executive Officer, Director, Promoter)
Board seatLauren P. Flickinger· per SEC Form D
Co-investorsHomebrewHealth Catalyst Capital
Tune Therapeutics develops a therapeutic platform targeting the epigenome to treat complex diseases and regenerative medicine applications.
BiotechDeep TechHealthtechLongevityMedical DevicesDurham and Seattle, US
Akira Matsuno(Co-Founder, President, CFO, COO)inDerek Jantz(Executive Officer)inCharles Gersbach(Co-Founder)inJohn McHutchison(CEO, Chairman of the Board)inDan McHugh(Co-Founder, Investor)inBlythe Sather(Executive Officer)in
Co-investorsDuke Capital PartnersMission BiocapitalNew Enterprise Associates (NEA)Pappas CapitalRV Invest GmbHSaisei Ventures+2 more
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
CREATE Medicines
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.